Antidepressants and customs: where permits are actually required

Most countries treat antidepressants as routine prescriptions. A small set — the Gulf states, Russia for a few molecules, Indonesia for amineptine — require permits or notarised paperwork. Here is the global picture of where it actually matters.

Antidepressants and customs: where permits are actually required

Most antidepressants travel without special attention from customs officers. In the United States, the EU, Canada, Australia, and most of Asia, SSRIs and SNRIs are routine prescriptions that move across borders with a doctor’s letter and original packaging. The exception is the Gulf states — UAE, Saudi Arabia, Qatar, and others — where many antidepressants are formally classified as controlled substances requiring advance import permits.

This guide covers customs and permit requirements. If your concern is brand-name continuity (your home medication being sold under a different name abroad), that is covered in our SSRI and SNRI guides, linked below.For brand-name and approval-status questions see our SSRI brand-names guide and SNRI withdrawal and prescription portability guide. For ADHD stimulants — a separate regulatory category from antidepressants — see our ADHD medication travel guide.

Medical disclaimer: This article provides general travel health information only. Drug scheduling, import regulations, and permit requirements change. Verify all rules with the official health authority of your destination country before travel, and consult your prescribing clinician before making any changes to your medication.

Why some antidepressants get caught at Gulf customs

Most SSRIs and SNRIs are not scheduled under the UN psychotropic conventions. Drug scheduling is set country by country, and Gulf Cooperation Council (GCC) states have built broader domestic schedules than most jurisdictions, capturing antidepressants with sedative or dual-action profiles. Federal Law by Decree No. 30 of 2021 in the UAE criminalises possession of narcotic and psychotropic substances without proper authorisation, and the scheduled list includes several commonly prescribed antidepressants.

Customs officers in those countries are not making an error when they flag your medication. They are enforcing a domestic schedule. The burden of proving legal importation falls on you, not on the officer.

United Arab Emirates

The UAE classifies controlled medications into two categories: Controlled Drug Class A (CD-A) for narcotic and psychotropic substances, and Controlled Drug Class B (CD-B) for semi-controlled medicines. Several antidepressants fall into one of these categories: mirtazapine, venlafaxine (Effexor), duloxetine (Cymbalta, CD-B specifically), amitriptyline, and clomipramine all appear on the UAE controlled lists. Standard SSRIs such as sertraline, fluoxetine, and escitalopram are generally not on the controlled lists at the time of writing, but verify your specific molecule before each trip.

Until late 2025 these import permits were administered by the Ministry of Health and Prevention (MOHAP) via the MOHAP portal. Effective 29 December 2025 the personal-use medicine import service moved to the Emirates Drug Establishment (EDE) at ede.gov.ae. The application process is otherwise unchanged: you submit a copy of your prescription, a signed doctor’s letter, and your travel dates, and you must receive approval before you fly. Approval is typically issued within a few business days but allow at least four weeks to be safe.

With an approved permit, visitors may carry up to a three-month supply; UAE residents may carry up to a twelve-month supply. Without a permit, controlled antidepressants can be seized at the border and the traveller may face administrative or criminal proceedings.

Saudi Arabia

Saudi Arabia’s Saudi Food and Drug Authority (SFDA) operates the Controlled Drugs System (CDS) at cds.sfda.gov.sa, an online permit application portal. Personal imports of controlled medications are capped at a 30-day supply for non-residents. Applications require the patient’s prescription, a medical report from the prescribing clinician, proof of identity, and travel dates.

Tricyclic antidepressants (amitriptyline, clomipramine, imipramine), SNRIs with dual serotonin-noradrenaline action (venlafaxine, duloxetine), and atypical antidepressants with sedative profiles (mirtazapine) attract more scrutiny than straightforward SSRIs. New regulations introduced in late 2024 require all travellers carrying controlled medications to apply through CDS regardless of stay duration.

Qatar, Bahrain, Oman, and Kuwait

Qatar prohibits travellers from carrying medicines containing narcotic or psychotropic substances without prior authorisation; medical reports, prescriptions, and original packaging are required for any controlled medication. Bahrain follows a similar pattern to Saudi Arabia with prescription and invoice requirements. Oman is the most permissive Gulf state — controlled-medication imports are allowed with a prescription issued within the last six months, and online ordering is permitted in limited quantities. Kuwait’s rules track the broader GCC framework, though enforcement specifics are not consistently published in English.

The practical rule across the Gulf: if your antidepressant has a sedative profile (mirtazapine), is a tricyclic (amitriptyline, clomipramine), or is an SNRI (venlafaxine, duloxetine), assume you need a permit and apply at least four weeks before you fly.

Other countries with antidepressant-specific rules

Russia: most SSRIs (fluoxetine, escitalopram, sertraline) travel without special restrictions, and fluoxetine is in fact widely available. However, anything on Russia's Schedule I, II, or III must be declared on entry with the medication name, quantity, and a notarised Russian translation of your prescription or medical report. Bupropion is the most-commonly-overlooked banned molecule: it is treated as a methcathinone derivative and possession can be prosecuted. If your treatment includes bupropion, switch to an alternative before travelling to Russia, or coordinate paperwork with the Russian embassy in advance.

Indonesia: under Law No. 5 of 1997 on psychotropic substances, only one antidepressant is scheduled — amineptine, a drug not prescribed in most Western countries. Every other antidepressant in routine clinical use (SSRIs, SNRIs, tricyclics, mirtazapine, agomelatine) is unscheduled. Foreign travellers may carry up to a 90-day personal supply when accompanied by a valid prescription; quantities beyond that require advance clearance through the BPOM (Indonesia's drug regulator) and customs.

Singapore: the Health Sciences Authority (HSA) sets the rule. You do not need advance approval for less than a three-month supply of any antidepressant that is not on Singapore's controlled-drug or psychotropic list (and standard SSRIs and SNRIs are not). For more than a three-month supply, or for any molecule on the controlled list, file an HSA Personal Medication application at least two weeks before travel. Always carry the original prescription and a doctor's letter; possession without supporting paperwork can be charged under the Misuse of Drugs Act.

Türkiye: most modern antidepressants travel as ordinary prescriptions, but a handful of benzodiazepine-class anxiolytics (notably chlordiazepoxide, clonazepam) appear on the banned list, so check the TİTCK database before relying on a co-prescribed benzo. Quantity guidance is a three-month supply maximum; bring the original prescription, ideally translated into Turkish, and keep medication in original packaging.

Countries where standard antidepressants travel routinely

A common misconception is that Japan, China, South Korea, and most of Southeast Asia classify standard antidepressants as controlled substances. They do not. SSRIs (fluoxetine, sertraline, escitalopram, citalopram, paroxetine), SNRIs (venlafaxine, duloxetine), atypicals (mirtazapine, bupropion), and tricyclics travel through these jurisdictions as ordinary prescription medication, subject only to general personal-import rules — typically a one- to three-month supply with the original prescription and a doctor's letter.

Japan is the most-frequently-confused destination. A Yakkan Shoumei (薬監証明) personal-import certificate from the Ministry of Health, Labour and Welfare is required only if your supply exceeds one month, or for a small number of stimulant ADHD drugs (Adderall is banned outright; Vyvanse and Concerta need advance permits). Standard SSRIs and SNRIs at a one-month supply pass through Japanese customs as ordinary prescriptions.

The EU/EEA, UK, United States, Canada, Australia, and New Zealand all treat antidepressants as routine prescriptions. Carry the medication in original packaging with a copy of your prescription, and customs is unlikely to ask more than confirmatory questions. The exception is anything controlled in your destination's home schedule (some MAOIs and certain benzodiazepine co-prescriptions) — verify those separately.

The document checklist that actually works at border control

A vague doctor’s letter does not satisfy a customs officer who needs to see a specific quantity, a diagnosis code, and a prescriber’s registration number. Use this checklist for every destination where your antidepressant may be controlled.

Original pharmacy-labelled packaging with your name, prescriber name, dosage, and quantity printed on the label.

A signed letter from your prescribing doctor on clinic letterhead, stating the INN (generic name), daily dose, diagnosis (or diagnostic code), and length of travel.

A copy of the original prescription, dated within 12 months.

Any country-specific permit (EDE permit for UAE, SFDA CDS permit for Saudi Arabia) obtained before departure.

A translated version of the letter if your destination country does not use English as an administrative language.

Keep all documents in your carry-on, not in checked luggage. Checked bags are not accessible during a customs inspection.

What to do if your supply runs short abroad

In Gulf states where your specific antidepressant is controlled, a local psychiatrist cannot simply write you a new prescription at a walk-in appointment. Controlled-drug prescriptions require a registered specialist and a formal diagnostic assessment, even if you have been stable on the same dose for years.

If you realise your supply is running low, contact a private psychiatric clinic early, not the day before you run out. In Dubai, Doha, or Riyadh, same-day psychiatric dispensing of a controlled antidepressant is not realistic. Bring a minimum 10 percent buffer quantity beyond your calculated trip dose to cover flight delays and itinerary changes.

Abrupt discontinuation of SSRIs and SNRIs carries a real risk of discontinuation syndrome. Symptoms can begin within 24 to 72 hours of a missed dose depending on the medication’s half-life. Fluoxetine has a long half-life and carries low discontinuation risk. Paroxetine and venlafaxine have shorter half-lives and higher risk. Plan your supply around the specific pharmacology of your medication, not a generic assumption.

Carrying your psychiatric history across borders

The HL7 International Patient Summary (IPS) standard was designed specifically to give clinicians the minimum dataset they need to treat a patient safely in an unplanned encounter. For psychiatric medications, that means your prescriber, your current dosage, your diagnosis, and any known contraindications are readable by a hospital in Dubai, Doha, or Riyadh without a fax machine or translator working from a scanned PDF.

An IPS record generated in Nomedic stores your medication list, dosages, and prescriber information in a format adopted across the EU and increasingly supported by international electronic health record vendors. If you end up in a foreign emergency department and cannot communicate, a clinician can read your current psychiatric medications from the structured record without relying on you to name them.

A practical pre-travel action plan

Confirm your molecule’s schedule. Look up your medication by its INN (generic name) on the health ministry website of every Gulf country you are entering, not just your final destination. Transit countries matter if you clear customs there.

Get documentation from your prescriber. A specific letter is more useful than a generic one. It should name the INN, the branded name, the dose in milligrams, the frequency, and the duration of your trip.

Apply for permits at least four weeks before travel. The UAE (EDE) and Saudi Arabia (SFDA CDS) both require advance applications. Embassy and portal processing times are not guaranteed.

Pack your full supply in carry-on luggage, in original packaging. Split a small emergency backup (no more than 3 to 5 days’ worth) into a second bag in case of bag loss.

Create or update your IPS record on Nomedic before you fly. Your prescribing doctor’s contact details, current medication list, and dosages will be accessible from your phone in any clinical setting.

Frequently asked questions

Does the UAE require a permit for all antidepressants?

Not all. Standard SSRIs (sertraline, fluoxetine, escitalopram) are typically not on the UAE controlled lists at the time of writing. SNRIs (venlafaxine, duloxetine), atypicals (mirtazapine), and tricyclics (amitriptyline, clomipramine) appear on the controlled schedule and require a permit. As of December 2025 the import permit service moved from MOHAP to the Emirates Drug Establishment (EDE) at ede.gov.ae. Verify your specific molecule before each trip — the list is updated periodically.

Which countries beyond the Gulf require permits for antidepressants?

Russia requires a notarised Russian translation of your prescription for anything on Schedules I-III, and bans bupropion outright. Singapore's HSA requires advance approval for stays longer than three months on any medication, or any amount of a controlled-list drug. Indonesia restricts amineptine specifically (rarely prescribed in Western countries). Most other jurisdictions — EU, UK, US, Canada, Australia, Japan, South Korea, China — treat standard antidepressants as routine prescriptions.

Are standard SSRIs and SNRIs controlled substances in Japan?

No. Japan’s Narcotics Control Department schedules psychotropic substances including methylphenidate, zolpidem, alprazolam, clonazepam, diazepam, and buprenorphine — but not standard SSRIs or SNRIs. You can carry up to a one-month supply of fluoxetine, sertraline, escitalopram, fluvoxamine, or venlafaxine without a Yunyu Kakunin-sho certificate. Anything above one month, like any prescription, requires the certificate.

What happens if my antidepressant is confiscated at Gulf customs?

If you have correct documentation, you can typically recover the medication after an administrative review. Without documentation, controlled medications may be permanently seized and you may face administrative or criminal proceedings under local law. Abrupt cessation of SSRIs and SNRIs can cause discontinuation syndrome within 24 to 72 hours, so always carry enough documentation to prevent seizure rather than relying on retrieval.

Do I need a doctor’s letter for antidepressants in the EU?

EU member states generally do not require a special permit for standard SSRIs or SNRIs carried in personal quantities. A valid prescription and original packaging are sufficient. A doctor’s letter adds useful detail but is not legally mandated in most EU countries.

How do I find out if my antidepressant is controlled in a specific country?

Search the destination health ministry website for the medication by its INN (international non-proprietary name, e.g. venlafaxine not Effexor). For the Gulf, check the UAE Embassy CD-A/CD-B lists and the Saudi SFDA Controlled Drugs System portal. For Russia, the UN ODC country profile lists Schedules I-III. For Singapore, the HSA personal-medication overview pages a controlled-drug checker. For other countries, the destination's embassy in your home country can confirm; allow 5-10 business days for a written response.

Antidepressants and customs: where permits are actually required